OMCL
OMNICELL, INC.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$35.81
+1.19%Year over year
Reported trailing growth
- Revenue
- +8.5%
- EBITDA
- +16.6%
- EBIT
- +237.9%
- EPS
- +71.0%
- Free cash flow
- +38.1%
- Operating cash flow
- +23.6%
Forward estimates
Based on analyst estimates
- Revenue
- +1.7%
- EBITDA
- +28.8%
- EPS
- +116.9%
Three-year CAGR
- Revenue
- -2.9%
- EBITDA
- +1.7%
- EBIT
- +3361.4%
- Net income
- -28.6%
- EPS
- -30.0%
- Free cash flow
- +72.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026